Prospective placebo‐controlled randomized trial of lexipafant in predicted severe acute pancreatitis
暂无分享,去创建一个
C. McKay | C. Imrie | J. Baxter | F. Curran | C. Sharples
[1] C. McKay,et al. A randomized, controlled trial of octreotide in the management of patients with acute pancreatitis , 1997, International journal of pancreatology : official journal of the International Association of Pancreatology.
[2] L. Czakó,et al. Time-course changes in serum cytokine levels in two experimental acute pancreatitis models in rats , 1996, Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie.
[3] K. Fearon,et al. Proinflammatory cytokine release by peripheral blood mononuclear cells from patients with acute pancreatitis , 1996, The British journal of surgery.
[4] C. McKay,et al. Increased monocyte cytokine production in association with systemic complications in acute pancreatitis , 1996, The British journal of surgery.
[5] M. Kotb,et al. Anti-TNFalpha therapy improves survival and ameliorates the pathophysiologic sequelae in acute pancreatitis in the rat. , 1996, American journal of surgery.
[6] M. Kotb,et al. Up-regulation of TNFα mRNA in the rat spleen following induction of acute pancreatitis , 1995 .
[7] L. Formela,et al. Randomized, double‐blind phase II trial of Lexipafant, a platelet‐activating factor antagonist, in human acute pancreatitis , 1995, The British journal of surgery.
[8] L. Wood,et al. Amelioration of experimental acute pancreatitis with a potent platelet‐activating factor antagonist , 1994, The British journal of surgery.
[9] G. Camussi,et al. Role of platelet activating factor in acute pancreatitis induced by lipopolysaccharides in rabbits. , 1994, European journal of pharmacology.
[10] H. Reber,et al. Clinically based classification system for acute pancreatitis. , 1993, Pancreas.
[11] E L Bradley,et al. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992. , 1993, Archives of surgery.
[12] P. Malfertheiner,et al. Gabexate mesilate in human acute pancreatitis , 1993 .
[13] A. Shenkin,et al. Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis. , 1993, Gut.
[14] J. Stachura,et al. Role of platelet activating factor in pathogenesis of acute pancreatitis in rats. , 1992, Gut.
[15] F. Carballo,et al. Role of interleukin-6 in acute pancreatitis. Comparison with C-reactive protein and phospholipase A. , 1992, Gut.
[16] J. Schölmerich,et al. lnterleukin‐8 and neutrophil activation in acute pancreatitis , 1992, European journal of clinical investigation.
[17] C. Scheibenbogen,et al. Elevation of serum interleukin-6 concentration precedes acute-phase response and reflects severity in acute pancreatitis. , 1991, Gastroenterology.
[18] C. Imrie,et al. Prediction of outcome in acute pancreatitis: A comparative study of APACHE II, clinical assessment and multiple factor scoring systems , 1990, The British journal of surgery.
[19] D. Hosford,et al. PAF/cytokine auto-generated feedback networks in microvascular immune injury: consequences in shock, ischemia and graft rejection. , 1989, Journal of lipid mediators.
[20] W. Hsueh,et al. Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet-activating factor. , 1988, The Journal of clinical investigation.
[21] P. Bell,et al. Multicentre clinical trial of low volume fresh frozen plasma therapy in acute pancreatitis , 1987, The British journal of surgery.
[22] R. Williamson,et al. Controlled clinical trial of peritoneal lavage for the treatment of severe acute pancreatitis. , 1985, The New England journal of medicine.
[23] M. Young,et al. Sample size nomograms for interpreting negative clinical studies. , 1983, Annals of internal medicine.
[24] J. C. Ferguson,et al. A single‐centre double‐blind trial of Trasylol therapy in primary acute pancreatitis , 1978, The British journal of surgery.
[25] O. Zelder,et al. Glucagon therapy in acute pancreatitis. Report of a double-blind trial. , 1978, Gut.
[26] J. Condon,et al. Glucagon therapy in acute pancreatitis , 1973, The British journal of surgery.
[27] M. Kotb,et al. Inhibition of TNFα improves survival in an experimental model of acute pancreatitis , 1996 .
[28] J. Hermon-Taylor,et al. Activation of human granulocyte type 1-prophospholipase A2. , 1996, Scandinavian journal of gastroenterology. Supplement.
[29] M. Kotb,et al. Inhibition of TNF alpha improves survival in an experimental model of acute pancreatitis. , 1996, The American surgeon.
[30] J. Marshall,et al. Multiple Organ Dysfunction Syndrome (MODS) , 1995 .
[31] M. Kotb,et al. Up-regulation of TNF alpha mRNA in the rat spleen following induction of acute pancreatitis. , 1995, The Journal of surgical research.
[32] P. Malfertheiner,et al. Gabexate mesilate in human acute pancreatitis. German Pancreatitis Study Group. , 1993, Gastroenterology.
[33] P. Braquet,et al. Effect of platelet-activating factor on monocyte activation and production of tumor necrosis factor. , 1989, International archives of allergy and applied immunology.